Is severely left ventricular dysfunction a predictor of early outcomes in patients with coronary artery bypass graft?

Seyed Hossein Ahmadi1, Abbasali Karimi1, Namvar Movahedi1

  • 1Cardiovascular Surgery Department, Tehran Heart Center, Medical Sciences, University of Tehran, Iran.

Heart Asia
|June 22, 2016
PubMed

Insights

Coronary artery bypass grafting (CABG) outcomes for patients with low ejection fraction (EF≤35%) were analyzed. Despite higher initial mortality risks, EF≤35% did not predict in-hospital mortality after adjustments, highlighting careful patient selection for CABG.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Outcomes Research

Background:

  • Traditionally, Coronary Artery Bypass Grafting (CABG) outcomes are worse for patients with low ejection fraction (EF).
  • The trend in outcomes for patients with low EF undergoing CABG has remained unclear despite surgical advancements.

Purpose of the Study:

  • To determine the effect of left ventricular dysfunction (EF≤35%) on early mortality and morbidity after isolated CABG.
  • To identify predictors of early mortality in patients with EF≤35% undergoing isolated CABG.

Main Methods:

  • Retrospective analysis of 14,819 patients undergoing isolated CABG (February 2002 - March 2008).
  • Patients were stratified into two groups: EF≤35% and EF>35%.
  • Propensity score matching was used to control for differences in patient characteristics.

Main Results:

  • Low ejection fraction (EF≤35%) was present in 9.1% of patients.
  • Univariate analysis showed increased in-hospital mortality for EF≤35%, but this association diminished after propensity score adjustment (p=0.242).
  • Renal failure, cardiac arrest, heart block, infectious complications, and longer ventilation/ICU times were more frequent in the EF≤35% group post-adjustment.

Conclusions:

  • Left ventricular ejection fraction ≤35% was not a predictor of in-hospital mortality in patients undergoing CABG.
  • Careful preoperative patient selection is crucial for patients with EF≤35% undergoing CABG.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
384
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
725
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
591
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
416
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
636
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K